INS and Hyperglycemia: Here, using a sensitive and specific glucagon assay, we show that exogenous GLP-2, compared to placebo, increases glucagon secretion only slightly during euglycemia, and not during hyperglycemia or insulin-induced hypoglycemia in healthy men.